Researchers have identified specific genes containing rare mutations that significantly increase the likelihood of developing ...

Attention deficit hyperactivity disorder (ADHD) is the most common disability diagnosis in children globally. It's estimated ...

ADHD can also lead to ill-health and is associated with a higher risk of premature mortality or shortened lifespan. This ...

Not long ago, most people thought of attention deficit hyperactivity disorder, or ADHD, as a childhood condition that would ...

Centanafadine is a first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor (NDSRI). Clinical studies have shown that centanafadine significantly reduces core symptoms of ADHD in ...

Structured physical exercise plus standard care compared with standard care alone may alleviate symptoms of adult ...

Groundbreaking research has uncovered a set of just three gene variants that can increase the likelihood of attention-deficit ...

Queensland is becoming the first jurisdiction in Australia to allow specialist GPs to diagnose ADHD in adults and prescribe ...

Once-daily Precision Timed Release™ (PTR™) stimulant designed to deliver rapid onset of effect and entire active-day duration NDA accepted under the FDA’s 505(b)(2) regulatory pathway KANSAS CITY, Kan ...

Co-occurring ADHD and substance use create unique challenges. The latest research shows what effective treatment really ...